Can I read Pediatric Safety Review of DENGVAXIA Vaccine on EtoBox?

Pediatric Safety Review of DENGVAXIA Vaccine by andersonln1184 is a document available to read on EtoBox.

What is Pediatric Safety Review of DENGVAXIA Vaccine about?

This memorandum reviews the safety and utilization of DENGVAXIA, a dengue vaccine approved for individuals aged 6 to 16 with previous dengue infection. It summarizes postmarketing safety data, including adverse event reports and pharmacovigilance plans, covering the period from May 1, 2019, to September 30, 2024. The document highlights that while there were reports of adverse events, no new safety concerns were identified, and the vaccine distribution is set to be discontinued by September 2025.

Author

andersonln1184

Language

EN